Hanmi Pharm Co Ltd (128940) — Cash Flow Quality Index
Hanmi Pharm Co Ltd (128940) has a Cash Flow Quality Index of 1.05x as of September 2025. Operating cash flow of ₩42.02 Billion exceeds net income of ₩40.13 Billion, indicating high earnings quality where cash backs reported profits. Explore Hanmi Pharm Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hanmi Pharm Co Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Hanmi Pharm Co Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Hanmi Pharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hanmi Pharm Co Ltd (2011–2024)
Year-by-year earnings quality comparison for Hanmi Pharm Co Ltd. For live market cap and the full company financial profile, see market cap of Hanmi Pharm Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.56x | ₩193.49 Billion | ₩124.27 Billion | ▲ +14.5% |
| 2023 | 1.36x | ₩216.54 Billion | ₩159.28 Billion | ▼ -35.6% |
| 2022 | 2.11x | ₩162.27 Billion | ₩76.93 Billion | ▼ -15.3% |
| 2021 | 2.49x | ₩201.92 Billion | ₩81.08 Billion | ▼ -80.3% |
| 2020 | 12.67x | ₩151.53 Billion | ₩11.96 Billion | ▲ +5204.9% |
| 2019 | 0.24x | ₩12.45 Billion | ₩52.11 Billion | ▼ -77.1% |
| 2018 | 1.04x | ₩25.98 Billion | ₩24.89 Billion | ▲ +200.3% |
| 2017 | -1.04x | ₩-62.91 Billion | ₩60.43 Billion | ▼ -105.9% |
| 2016 | 17.70x | ₩412.97 Billion | ₩23.33 Billion | ▲ +2588.3% |
| 2015 | 0.66x | ₩101.71 Billion | ₩154.44 Billion | ▲ +171.3% |
| 2014 | -0.92x | ₩-32.82 Billion | ₩35.51 Billion | ▼ -147.2% |
| 2013 | 1.96x | ₩85.99 Billion | ₩43.93 Billion | ▼ -30.0% |
| 2012 | 2.79x | ₩63.27 Billion | ₩22.64 Billion | ▼ -94.1% |
| 2011 | 47.46x | ₩61.30 Billion | ₩1.29 Billion | — |